Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phage-CLEAR: Phage-based Control and Limitation of Pathobionts for Microbiome Equilibrium and Resilience

NCT07816809 is registered in ClinicalTrials.gov with Colorado State University as lead sponsor.

NCT NCT07816809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07816809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phage-CLEAR: Phage-based Control and Limitation of Pathobionts for Microbiome Equilibrium and Resilience
Lead sponsor
Colorado State University
Phase
Not applicable
Overall status
Recruiting
Start date
September 14, 2026
Completion date
January 31, 2028
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal symptoms, skin quality